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ABSTRACT 
Purpose: The search for cause of death is important to improve knowledge and provide 
answers for the deceased’s relatives. Medical autopsy following unexplained death in hospital 
is one way to identify cause of death, but difficult to carry out routinely. Post mortem 
sampling (PMS) of tissues via thin biopsy needle or “mini incisions” in the skin may be a 
useful alternative. We aimed to assess how this approach is perceived by intensive care 
doctors, and secondarily, to evaluate how this practice is considered in ethical terms in 
France. 
Methods: Study of PMS practices immediately after death in 10 intensive care departments. 
The medical director of each centre was interviewed by phone and asked to describe practices 
in their unit and identify questions raised concerning this practice.  
Results: PMS is routinely performed in 70% of units, without obtaining formal consent and 
without precise rules for communicating results. Approaches to PMS differed between 
centres, but all physicians felt that PMS is useful, firstly for the scientific information 
provided, but also for the information it provides for relatives. All physicians regret the lack 
of standards to structure PMS practices.  
Conclusion: Information from post-mortem examination is important for society, to inform 
about causes of death; for doctors, to improve practices; and for decision-makers responsible 
for organising care. Debate persists regarding the balance between individual rights and 
community interests. We purport that an approach for identifying cause of death could easily 
be integrated into the relationship between carers and relatives, provided full transparency is 
maintained. 
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INTRODUCTION AND OBJECTIVES 
One of the major preoccupations of doctors, beyond patient care, is identifying the 
reasons for the death of a patient. The search for a cause of death is important, to provide 
answers to the inevitable questions from close relatives of the deceased. The search for the 
cause of death is also important to broaden knowledge, particularly in deaths where the cause 
of death is unclear, with a view to improving diagnostic and therapeutic strategies, and more 
generally, quality of care.[1-4]  
This approach is one of the missions of public health and may contribute to changes in 
health policy in terms of care and prevention. It should improve our understanding of the 
causes of death, and such improvements are necessary for the compulsory rigorous 
completion of the section devoted to cause of death on death certificates. This section is used 
to compile national statistics every year.  
 In the setting of intensive care, progress in diagnostic techniques (imaging, endoscopy, 
biological tests etc.) performed while the patient is alive has considerably reduced uncertainty 
in this area. However, the causes of death or the circumstances leading to death in intensive 
care may often remain unexplained or unclear.[5-11] This is a particular problem in intensive 
care, because the extensive technological interventions may mask physiopathological 
conditions, or even generate new ones, thus creating new and more complicated causes of 
death.[12,13] A recent study of 167 autopsies carried out between 2001 and 2003 in a non-
surgical intensive care unit in Paris identified a large number of cases of mistaken diagnosis, 
with a major difference between medical diagnosis and the cause of death identified on 
medical autopsy in almost 32% of cases.[14] Another study demonstrated that, for deaths 
occurring in the 10 days following admission, the autopsy revealed discrepancies between the 
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clinical diagnosis and the actual cause of death.[15] Finally, Weustink et al [16] recently 
showed that combining post-mortem MRI and CT scanning with ultrasonography-guided 
necropsies (a procedure they named ‘minimal invasive autopsy’) enabled the cause of death to 
be identified or confirmed. 
Medical autopsy following an unexplained death in hospital is recognised as one way 
to identify the cause of death. However, systematic autopsy is difficult to carry out in practice, 
due to organisational and ethical problems.[17,18]  
Nonetheless, the need to know the real cause of death often persists, both for the 
medical staff and for the relatives. The lack of post mortem examination is an integral 
component of this debate. Indeed, the information provided by autopsy can assist in the 
mourning process, and may have medical implications for the relatives. Post mortem 
sampling (PMS) of tissues by the intensive care doctor, by means of a fine biopsy needle or 
via ‘mini incisions’ in the skin, may make a useful contribution to the search for the cause of 
death.[19-21] Such samples can only be taken from certain easily accessible organs (most 
frequently the liver and lungs, or more rarely, the kidneys) and result in only small, discreet 
breaks in the skin. They could never entirely replace a conventional autopsy [19], as they do 
not provide morphological or macroscopic information. However, they are easy to carry out 
and appear less traumatic, and they may therefore be more acceptable to professionals and 
seen in a better light by relatives.  
 Aside from these hypotheses, even though PMS may have the same goals as autopsy 
(etymologically, “seeing for yourself”), the questions raised by the implementation of such an 
approach must be discussed with a view to structuring this practice, if it is to develop in the 
future. This approach would integrate into a continuum of care for the person, extending from 
life into death. 
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 In France, the so-called bioethics laws of 2004 [22] are based on the principle of 
presumed consent for sampling from corpses, namely that samples may be taken for scientific 
or therapeutic purposes as long as the patient did not object to such sampling during their 
lifetime. Such objections can have been recorded in the national registry of refusals, or may 
be reported by relatives. However, these procedures for recording refusal seem to have been 
thought out with an eye to traditional medical autopsy on the one hand, and organ donation on 
the other. It remains unclear whether they are relevant to PMS. 
We therefore carried out a study in a selection of intensive care departments, to 
evaluate, firstly, how this approach was perceived by intensive care doctors, and secondly, 
how this practice could be considered in ethical terms in France. 
 
METHODS 
We carried out a study on the practice of tissue sampling immediately after death in 
collaboration with adult intensive care departments. This study aimed to identify the ethical 
questions raised by intensive care professionals engaged in this emerging practice. Key 
questions posed concerned access to the corpse, the question of consent that this access 
entails, and the wider issue of informing the relatives. Thirty two French intensive care 
departments were initially contacted by email (16 university teaching hospitals, and 16 non-
academic general hospitals). In total, ten centres accepted to answer (4 university hospitals, 6 
general hospitals representing 6 medical and 4 surgical intensive care units). 
The medical director of each centre participating in the study was contacted and asked 
to describe the practice of this technique in their department. 
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RESULTS 
Questions raised in practice 
Frequency, indications and technique  
All 10 participating centres were interested in identifying the cause of death. Seven 
centres performed post-mortem sampling. The other three did not carry out PMS as they were 
able to carry out conventional autopsy. 
None of the centres systematically carried out PMS for every death and none could 
cite the precise frequency of these acts. However, the clinical conditions leading to this type 
of sampling were clearly identified and the reasons were identical in all cases, namely PMS 
was performed if the death was unexplained or the circumstances leading to the death were 
unclear. The scientific value of this approach was always cited. Three departments indicated 
that PMS improved their evaluations of morbidity and mortality, particularly as autopsy was 
not always possible. In cases of potential conflict in which the responsibility of the doctor 
might be invoked, all the doctors called for medico-legal autopsy rather than carrying out a 
medical autopsy or PMS.   
Samples of lung, liver and kidney were usually taken. Liver and kidney samples were 
taken with a fine biopsy needle passed through the skin without the need for an incision. Lung 
samples were taken with a fine needle or surgically, with the creation of a small skin incision. 
Most of the doctors informed the personnel present of the reasons for which PMS was 
carried out and explained that the performance of such procedures should be taken into 
account in the overall management of the deceased. They recognised that it was essential to 
inform the care team, because this practice slightly delays the preparation of the body for 
viewing and the admission of the patient’s family to the room.  
All post mortem samples were sent to the pathology laboratory or the microbiology 
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laboratory, as appropriate. None of the specimens were kept in the department or in a tissue 
library in the laboratory for an extended period. The samples were studied under the same 
conditions and in the same time frame as samples taken from living patients.    
 
Questions relating to routine application of PMS 
Only one department had a written protocol for PMS. None of the departments 
considered this practice to be a research protocol. Most considered it to be a continuation of 
general care, part of the diagnostic process and good medical practice. Consistent with this 
view, none of the centres felt that it needed to be covered by the French law on biomedical 
research or submitted to an institutional review board for approval. 
 
Prior information and consent 
Three centres declared that they informed relatives before performing PMS. The 
reasons given for informing the relatives were similar in all cases: obtaining explicit consent 
from the family (rather than views concerning the patient’s wishes), with a view to achieving 
transparency and helping the relatives to deal with this procedure being carried out. The 
information given always clearly stated that the appearance of the body would be preserved.   
The doctors stated that this information was well received by relatives, whose 
perception of this medical approach was favourable. Relatives accepted PMS because they 
wanted to understand and know the cause of death. The fact that the patient’s body was not 
violated contributed to increasing relatives’ acceptance. 
One centre consulted the national register of refusals before meeting relatives, to 
determine whether the patient had objected to medical autopsy during his or her lifetime. This 
department extrapolates this information, to establish an analogy between medical autopsy 
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and PMS. 
The centres that did not inform the relatives cited as justification the painful 
experience of asking permission from the family, and the fact that seeking consent from the 
family does not legitimise the procedure, since the relatives’ opinions do not necessarily 
reflect the patient’s wishes. They also highlighted the lack of any legal obligation to seek 
consent from the family.  
 
Communicating the results 
The results were systematically communicated to the relatives by six of the seven 
centres that carried out PMS. For these centres, providing the results was an integral part of a 
policy of transparency with respect to the relatives, and contributed to the continuity of 
management.  
 The only centre that did not systematically inform families of the results cited the 
mainly scientific motivation for the sampling and the absence of a direct benefit to the 
deceased or their family.  
 All the centres that informed the family before taking samples recognised that this 
initial communication made it easier to provide additional information subsequently.   
Concerning the nature of results communicated and the respect of medical 
confidentiality, the families were provided with any results that could have a potential impact 
on the health of relatives, as well as results that contributed to a better understanding of the 
reasons for the patient’s death. These centres said that they communicated the results for 
reasons of transparency. Some of the centres questioned therefore stressed the need to adapt 
the information in order to respect medical confidentiality and the interests of the relatives on 
a case-by-case basis. 
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DISCUSSION 
Autopsy has contributed to the advancement of medical knowledge. Elements from the 
post-mortem examination of a body are important for society, which needs to be informed 
(and/or enlightened) about the causes of death of its members, not only for doctors, to help 
them to improve their practices, but also for the decision-makers responsible for organising 
care. Medicine is a social practice that aims to cure the individual and to meet the objectives 
of public health, notably through the duty of the doctor to understand the causes of death. 
Thus, in any approach to post mortem diagnosis, there is a debate about the balance between 
respecting the rights of the individual and the interests of the community. 
 Our study shows that samples are taken as a matter of course as part of the care 
process, without formal consent being sought and without any precise rules concerning the 
communication of information. Weustink et al [16] mention that informed consent was 
obtained, but do not explain at which timepoint, or from whom it was obtained. In France, 
obtaining consent for autopsy from a patient on admission to intensive care is felt to be 
contrary to the psychological well-being of the patient, as this request raises the possibility of 
death. Resorting to the alternative principle of presumed consent would require that all 
citizens be aware of this issue, making it possible for them to object by formally recording 
their refusal while still in good health. 
If PMS were to become common practice in the future, all those concerned (doctors, 
representatives of civil society, patients’ associations) should discuss the regulations required. 
This question will be particularly important when bioethics laws are to be updated [22]. These 
laws do not currently consider the issue of PMS in France.  
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Consent 
The legitimacy of PMS is important from a medical, scientific and societal point of 
view, but the right of the individual to make his or her own decision in this domain must be 
taken into consideration. 
Presumed consent, a principle initially developed for organ donation in France, is 
sometimes taken as a reference for PMS. According to this principle, it is presumed that, in 
the absence of any objection made during the lifetime of the patient, samples can be taken. 
Objection to sampling can be made in two ways in France: 
- By informing relatives, who can then provide information about the wishes of the 
deceased (but should not express their own point of view). 
- By recording their objection in the national registry of refusals, maintained by the 
National Agency of Biomedicine, under the responsibility of the Ministry of 
Health. 
 This principle, with the interests of the community as the overriding factor, could serve 
as a reference for PMS. Indeed, PMS is also in the best interests of the community: a better 
understanding of the causes of death advances medical knowledge, leading to better care and 
organisation in intensive care departments. However, for the sake of consistency, the national 
registry of refusals should include a specific right to object to PMS, by distinguishing 
between PMS, medical autopsy and organ or tissue donation.   
 The wording in the registry of refusals currently reads: ‘I object to the donation of my 
body for medical research regarding the cause of death (autopsy, except forensic autopsy, to 
which objection is not possible)’.[23] PMS is therefore neither recognised nor specifically 
taken into account in this approach to refusal. In addition, no specific information program 
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concerning the unknown topic of PMS has been developed for the general public. The rule of 
presumed consent, applied in the present context of a complete lack of information of the 
public, does not appear to be ethically acceptable as regards respect for the freedom of choice. 
 A possible alternative model is that of explicit consent during the patient’s lifetime, 
following information of the general population at precise moments in the life of an individual 
(for example, when obtaining a driving licence or taking out health insurance). Indeed, a 
system based on explicit consent has been widely adopted internationally, particularly for 
organ donation.  For example, in most Canadian provinces, people can voluntarily sign a 
register during their lifetime to give consent for subsequent organ donation.[24] Adopting this 
approach in France would mean abandoning the principle of presumed consent in favour of a 
system in which individuals have more autonomy and must explicitly commit themselves. 
Indeed, it should be stressed that the principle of ‘presumed consent’ is not in line with a 
society in which there is increasing emphasis on the right of patients to make free and 
informed choices on all aspects related to their health.[25] Another argument in favour of 
explicit consent is the dependence of this approach on the education of citizens and positive 
solidarity, contrasting with implicit consent, which may conceal a lack of knowledge or 
misunderstanding. However, the choice of a system based on explicit consent would require 
public authorities to organise themselves so as to reach all citizens, to increase awareness and 
ask people to make their choices known. This would represent a democratic choice with 
repercussions for the organisation of the public sector and budget decisions. 
 A third model would involve consulting the relatives of the deceased (unless the 
deceased had made specific provision for this situation whilst still alive) because, although the 
body does not legally belong to the relatives, they are responsible for managing the death and 
the funeral rites. The relatives are in fact trustees responsible for organising the funeral and 
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respect of the body, based on the beliefs of the deceased. They may therefore be considered 
legitimate representatives of the deceased, able to agree to or to oppose the removal of 
samples. This approach also fits into a more general framework of autonomy of the 
individual, and favours the choices of individuals and their families. It makes it possible to 
take into account the psychological status of mourning relatives and the religious dimension, 
which may include the need for an intact body.[26,27] However, one of the problems of this 
approach is that it may not necessarily reflect the choices or wishes of the deceased. 
A fourth and final approach can also be considered, in which there is no need for 
specific consent, PMS being considered as a legitimate extension of the intensive care 
process. This approach is consistent with the missions of public health and would in the best 
interests of society, where improvements in medical knowledge are for the greater good. In 
some medical or socio-medical fields, individual autonomy is relative or overridden, in a 
social contract in which the interests of society have precedence. 
Indeed, in some cases, the medical profession can overrule personal choice, in the 
name of solidarity and for the public good (e.g. vaccination programmes, medico-legal 
autopsies, compulsory notification and treatment of certain contagious diseases etc.). This last 
option, by allowing systematic PMS, appears to be the most suitable from an epidemiological 
and scientific point of view. PMS would then be complementary to the national survey of 
causes of death, which is based on death certificates.[28] These compulsory certificates are 
drawn up without the consent of the patients or the relatives, because they are simply 
considered to be of fundamental importance to the community. PMS could be viewed in a 
similar way: despite its limitations, this technique, with our without medical imaging, could 
increase our understanding and, in the long term, improve the care of patients admitted to 
intensive care departments. The use of such an approach would require public debate, as it 
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entails an erosion of individual autonomy in favour of the interests of society. This approach 
would clearly involve the acceptance of a utilitarian dimension of medical science, with the 
aim of ensuring progress for the common good.   
 
Informing the relatives 
Information of the next of kin is possible, with no risk of violating medical 
confidentiality, in that French public health law permits the transmission of information 
enabling the relatives to ‘understand the cause of death, preserve the memory of the deceased 
or exercise their rights, on condition that the deceased did not object during his lifetime’.   
According to medical deontology, any information may be communicated to relatives, 
as long as it does not tarnish the image of the deceased. Healthcare professionals therefore 
need to prevent the transmission of medical results reflecting on the behaviour, personal and 
private life of the patient or of any other revelation deemed sensitive. In all other situations, 
the principle of transparency with respect to the relatives should prevail.[29] This approach 
should prevent the development of suspicions or difficult situations arising from unfortunate 
revelations. Transparency and dialogue are the foundations of confidence.  
Information is fundamental because it satisfies several levels of need [30]. Firstly, it 
enables the family to determine whether the approach is of medical interest to the community 
or themselves (advantage of being aware of an inherited illness, death from a professional 
illness leading to a right to compensation etc.). Secondly, it provides an opportunity to explain 
to the relatives that they may, if they wish, receive information about the cause of death 
(unless the patient had expressly demanded that no information be communicated or if there is 
a risk of revealing information that might tarnish the image of the deceased). Thirdly, even if 
information is available, it may be of purely epidemiological interest only, and not of 
 14 
individual interest, apart from contributing to understanding the cause of death and thereby, 
aiding the process of mourning. Finally, it is important to understand and accept that the 
procedure may be of no consequence, and may provide no information whatsoever. 
This information about the results is certainly one of the most important points. It is 
reasonable to think that providing this information may help distressed families, and 
contribute to establishing, maintaining, or even repairing a relation of confidence between 
relatives and doctors.[31] 
If PMS provides new data, it may be possible to give some meaning to a death that 
would otherwise have remained unexplained. Removing doubts about the cause of death may 
help relatives to mourn. Clinicians have generally found that this approach may alleviate 
feelings of guilt in relatives who feel that they did not do enough for the patient or that they 
didn’t seek help quickly enough, whereas in fact, the death was unavoidable in any case. 
     
CONCLUSION 
In the light of these findings, choices must clearly be made before PMS can be widely 
implemented. New standards, in addition to technical and scientific objectives, should take 
into account the issues identified. Thus, the idea that an approach to identify the cause of 
death could be seen as a necessary practice, carried out with full transparency, at a time when 
the clinical situation is deteriorating, could be integrated easily into the relationship between 
carers and relatives.   
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